PDB Short entry for 4EJN HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-APR-12 4EJN TITLE CRYSTAL STRUCTURE OF AUTOINHIBITED FORM OF AKT1 IN COMPLEX WITH N-(4- TITLE 2 (5-(3-ACETAMIDOPHENYL)-2-(2-AMINOPYRIDIN-3-YL)-3H-IMIDAZO[4,5- TITLE 3 B]PYRIDIN-3-YL)BENZYL)-3-FLUOROBENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTEIN KINASE B, PKB, PROTEIN KINASE B ALPHA, PKB ALPHA, COMPND 5 PROTO-ONCOGENE C-AKT, RAC-PK-ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT1, PKB, RAC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS AKT1, AUTOINHIBITION, ALLOSTERIC INHIBITOR, KINASE INHIBITOR, KEYWDS 2 HYDROPHOBIC COLLAPASE, KINASE, ATPASE, TRANSFERASE-TRANSFERASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.EATHIRAJ REVDAT 2 02-JAN-13 4EJN 1 JRNL REVDAT 1 23-MAY-12 4EJN 0 JRNL AUTH M.A.ASHWELL,J.M.LAPIERRE,C.BRASSARD,K.BRESCIANO,C.BULL, JRNL AUTH 2 S.CORNELL-KENNON,S.EATHIRAJ,D.S.FRANCE,T.HALL,J.HILL, JRNL AUTH 3 E.KELLEHER,S.KHANAPURKAR,D.KIZER,S.KOERNER,J.LINK,Y.LIU, JRNL AUTH 4 S.MAKHIJA,M.MOUSSA,N.NAMDEV,K.NGUYEN,R.NICEWONGER,R.PALMA, JRNL AUTH 5 J.SZWAYA,M.TANDON,U.UPPALAPATI,D.VENSEL,L.P.VOLAK, JRNL AUTH 6 E.VOLCKOVA,N.WESTLUND,H.WU,R.Y.YANG,T.C.CHAN JRNL TITL DISCOVERY AND OPTIMIZATION OF A SERIES OF JRNL TITL 2 3-(3-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINES: JRNL TITL 3 ORALLY BIOAVAILABLE, SELECTIVE, AND POTENT ATP-INDEPENDENT JRNL TITL 4 AKT INHIBITORS. JRNL REF J.MED.CHEM. V. 55 5291 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22533986 JRNL DOI 10.1021/JM300276X REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 24706 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1317 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1707 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2939 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 165 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.68000 REMARK 3 B22 (A**2) : -0.67000 REMARK 3 B33 (A**2) : 1.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.271 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.220 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.184 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.161 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.915 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3072 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4167 ; 1.268 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 371 ; 5.920 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 133 ;35.514 ;23.910 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 479 ;16.739 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;20.103 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 449 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2343 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1866 ; 0.626 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2969 ; 1.184 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1206 ; 1.517 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1198 ; 2.594 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4EJN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-APR-12. REMARK 100 THE RCSB ID CODE IS RCSB071701. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : DOUBLE SILICON(111) CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26311 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% BUTANOL, 10MM AMMONIUM SULFATE, REMARK 280 0.1% 2-MERCAPTOETHANOL, 15% ETHYLENE GLYCOL, 50MM TRIS , PH 7.5, REMARK 280 EVAPORATION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.25400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.46800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.10700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.46800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.25400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.10700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 SER A 2 REMARK 465 ASP A 3 REMARK 465 GLN A 43 REMARK 465 ASP A 44 REMARK 465 VAL A 45 REMARK 465 ASP A 46 REMARK 465 GLN A 47 REMARK 465 ARG A 48 REMARK 465 GLU A 49 REMARK 465 LEU A 110 REMARK 465 LYS A 111 REMARK 465 LYS A 112 REMARK 465 GLN A 113 REMARK 465 ALA A 114 REMARK 465 ALA A 115 REMARK 465 ALA A 116 REMARK 465 GLU A 117 REMARK 465 MET A 118 REMARK 465 ASP A 119 REMARK 465 PHE A 120 REMARK 465 ARG A 121 REMARK 465 SER A 122 REMARK 465 GLY A 123 REMARK 465 SER A 124 REMARK 465 PRO A 125 REMARK 465 SER A 126 REMARK 465 ASP A 127 REMARK 465 ASN A 128 REMARK 465 SER A 129 REMARK 465 GLY A 130 REMARK 465 ALA A 131 REMARK 465 GLU A 132 REMARK 465 GLU A 133 REMARK 465 MET A 134 REMARK 465 GLU A 135 REMARK 465 VAL A 136 REMARK 465 SER A 137 REMARK 465 LEU A 138 REMARK 465 ALA A 139 REMARK 465 LYS A 140 REMARK 465 PRO A 141 REMARK 465 LYS A 142 REMARK 465 HIS A 143 REMARK 465 ALA A 188 REMARK 465 LYS A 189 REMARK 465 ASP A 190 REMARK 465 GLU A 191 REMARK 465 VAL A 192 REMARK 465 ALA A 193 REMARK 465 HIS A 194 REMARK 465 THR A 195 REMARK 465 LEU A 196 REMARK 465 THR A 197 REMARK 465 GLU A 198 REMARK 465 ASN A 199 REMARK 465 ARG A 200 REMARK 465 ASP A 302 REMARK 465 GLY A 303 REMARK 465 ALA A 304 REMARK 465 THR A 305 REMARK 465 MET A 306 REMARK 465 ASP A 439 REMARK 465 GLU A 440 REMARK 465 GLU A 441 REMARK 465 PHE A 442 REMARK 465 THR A 443 REMARK 465 ALA A 444 REMARK 465 GLN A 445 REMARK 465 MET A 446 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 4 CG1 CG2 REMARK 470 ARG A 15 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 20 CG CD CE NZ REMARK 470 ARG A 23 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 31 CG OD1 ND2 REMARK 470 ILE A 36 CG1 CG2 CD1 REMARK 470 LYS A 39 CG CD CE NZ REMARK 470 ARG A 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 ARG A 67 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 69 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 94 CG CD OE1 OE2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 ASP A 108 CG OD1 OD2 REMARK 470 ARG A 144 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 ARG A 174 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 184 CG CD OE1 OE2 REMARK 470 VAL A 185 CG1 CG2 REMARK 470 VAL A 201 CG1 CG2 REMARK 470 GLN A 203 CG CD OE1 NE2 REMARK 470 ARG A 206 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 ARG A 241 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 243 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 298 CG CD OE1 OE2 REMARK 470 ILE A 300 CG1 CG2 CD1 REMARK 470 LYS A 301 CG CD CE NZ REMARK 470 LYS A 307 CG CD CE NZ REMARK 470 ARG A 346 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 355 CG CD OE1 OE2 REMARK 470 LYS A 356 CG CD CE NZ REMARK 470 ARG A 370 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 389 CG CD CE NZ REMARK 470 LYS A 426 CG CD CE NZ REMARK 470 GLN A 428 CG CD OE1 NE2 REMARK 470 VAL A 429 CG1 CG2 REMARK 470 ARG A 436 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 20 108.24 -39.07 REMARK 500 TRP A 80 -101.97 63.01 REMARK 500 ALA A 107 78.99 -66.40 REMARK 500 ARG A 243 -47.73 78.65 REMARK 500 ASP A 274 26.58 -140.51 REMARK 500 ASP A 398 -125.71 52.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0R4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SBT A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 503 DBREF 4EJN A 2 446 UNP P31749 AKT1_HUMAN 2 446 SEQADV 4EJN GLY A 1 UNP P31749 EXPRESSION TAG SEQADV 4EJN ALA A 114 UNP P31749 GLU 114 ENGINEERED MUTATION SEQADV 4EJN ALA A 115 UNP P31749 GLU 115 ENGINEERED MUTATION SEQADV 4EJN ALA A 116 UNP P31749 GLU 116 ENGINEERED MUTATION SEQRES 1 A 446 GLY SER ASP VAL ALA ILE VAL LYS GLU GLY TRP LEU HIS SEQRES 2 A 446 LYS ARG GLY GLU TYR ILE LYS THR TRP ARG PRO ARG TYR SEQRES 3 A 446 PHE LEU LEU LYS ASN ASP GLY THR PHE ILE GLY TYR LYS SEQRES 4 A 446 GLU ARG PRO GLN ASP VAL ASP GLN ARG GLU ALA PRO LEU SEQRES 5 A 446 ASN ASN PHE SER VAL ALA GLN CYS GLN LEU MET LYS THR SEQRES 6 A 446 GLU ARG PRO ARG PRO ASN THR PHE ILE ILE ARG CYS LEU SEQRES 7 A 446 GLN TRP THR THR VAL ILE GLU ARG THR PHE HIS VAL GLU SEQRES 8 A 446 THR PRO GLU GLU ARG GLU GLU TRP THR THR ALA ILE GLN SEQRES 9 A 446 THR VAL ALA ASP GLY LEU LYS LYS GLN ALA ALA ALA GLU SEQRES 10 A 446 MET ASP PHE ARG SER GLY SER PRO SER ASP ASN SER GLY SEQRES 11 A 446 ALA GLU GLU MET GLU VAL SER LEU ALA LYS PRO LYS HIS SEQRES 12 A 446 ARG VAL THR MET ASN GLU PHE GLU TYR LEU LYS LEU LEU SEQRES 13 A 446 GLY LYS GLY THR PHE GLY LYS VAL ILE LEU VAL LYS GLU SEQRES 14 A 446 LYS ALA THR GLY ARG TYR TYR ALA MET LYS ILE LEU LYS SEQRES 15 A 446 LYS GLU VAL ILE VAL ALA LYS ASP GLU VAL ALA HIS THR SEQRES 16 A 446 LEU THR GLU ASN ARG VAL LEU GLN ASN SER ARG HIS PRO SEQRES 17 A 446 PHE LEU THR ALA LEU LYS TYR SER PHE GLN THR HIS ASP SEQRES 18 A 446 ARG LEU CYS PHE VAL MET GLU TYR ALA ASN GLY GLY GLU SEQRES 19 A 446 LEU PHE PHE HIS LEU SER ARG GLU ARG VAL PHE SER GLU SEQRES 20 A 446 ASP ARG ALA ARG PHE TYR GLY ALA GLU ILE VAL SER ALA SEQRES 21 A 446 LEU ASP TYR LEU HIS SER GLU LYS ASN VAL VAL TYR ARG SEQRES 22 A 446 ASP LEU LYS LEU GLU ASN LEU MET LEU ASP LYS ASP GLY SEQRES 23 A 446 HIS ILE LYS ILE THR ASP PHE GLY LEU CYS LYS GLU GLY SEQRES 24 A 446 ILE LYS ASP GLY ALA THR MET LYS THR PHE CYS GLY THR SEQRES 25 A 446 PRO GLU TYR LEU ALA PRO GLU VAL LEU GLU ASP ASN ASP SEQRES 26 A 446 TYR GLY ARG ALA VAL ASP TRP TRP GLY LEU GLY VAL VAL SEQRES 27 A 446 MET TYR GLU MET MET CYS GLY ARG LEU PRO PHE TYR ASN SEQRES 28 A 446 GLN ASP HIS GLU LYS LEU PHE GLU LEU ILE LEU MET GLU SEQRES 29 A 446 GLU ILE ARG PHE PRO ARG THR LEU GLY PRO GLU ALA LYS SEQRES 30 A 446 SER LEU LEU SER GLY LEU LEU LYS LYS ASP PRO LYS GLN SEQRES 31 A 446 ARG LEU GLY GLY GLY SER GLU ASP ALA LYS GLU ILE MET SEQRES 32 A 446 GLN HIS ARG PHE PHE ALA GLY ILE VAL TRP GLN HIS VAL SEQRES 33 A 446 TYR GLU LYS LYS LEU SER PRO PRO PHE LYS PRO GLN VAL SEQRES 34 A 446 THR SER GLU THR ASP THR ARG TYR PHE ASP GLU GLU PHE SEQRES 35 A 446 THR ALA GLN MET HET 0R4 A 501 43 HET SBT A 502 5 HET EDO A 503 4 HETNAM 0R4 N-(4-{5-[3-(ACETYLAMINO)PHENYL]-2-(2-AMINOPYRIDIN-3- HETNAM 2 0R4 YL)-3H-IMIDAZO[4,5-B]PYRIDIN-3-YL}BENZYL)-3- HETNAM 3 0R4 FLUOROBENZAMIDE HETNAM SBT 2-BUTANOL HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 0R4 C33 H26 F N7 O2 FORMUL 3 SBT C4 H10 O FORMUL 4 EDO C2 H6 O2 FORMUL 5 HOH *165(H2 O) HELIX 1 1 LEU A 52 SER A 56 5 5 HELIX 2 2 THR A 92 ALA A 107 1 16 HELIX 3 3 THR A 146 ASN A 148 5 3 HELIX 4 4 LYS A 183 VAL A 187 1 5 HELIX 5 5 GLU A 234 ARG A 243 1 10 HELIX 6 6 SER A 246 LYS A 268 1 23 HELIX 7 7 LYS A 276 GLU A 278 5 3 HELIX 8 8 THR A 312 LEU A 316 5 5 HELIX 9 9 ALA A 317 ASP A 323 1 7 HELIX 10 10 ARG A 328 GLY A 345 1 18 HELIX 11 11 ASP A 353 GLU A 364 1 12 HELIX 12 12 GLY A 373 LEU A 384 1 12 HELIX 13 13 ASP A 398 GLN A 404 1 7 HELIX 14 14 HIS A 405 ALA A 409 5 5 HELIX 15 15 VAL A 412 GLU A 418 1 7 SHEET 1 A 6 PHE A 35 TYR A 38 0 SHEET 2 A 6 THR A 21 LYS A 30 -1 N TYR A 26 O TYR A 38 SHEET 3 A 6 ILE A 6 GLY A 16 -1 N GLY A 16 O THR A 21 SHEET 4 A 6 THR A 82 HIS A 89 -1 O HIS A 89 N HIS A 13 SHEET 5 A 6 THR A 72 GLN A 79 -1 N CYS A 77 O ILE A 84 SHEET 6 A 6 GLN A 61 THR A 65 -1 N GLN A 61 O ARG A 76 SHEET 1 B 5 PHE A 150 GLY A 159 0 SHEET 2 B 5 GLY A 162 GLU A 169 -1 O LEU A 166 N LYS A 154 SHEET 3 B 5 TYR A 175 LYS A 182 -1 O ILE A 180 N LYS A 163 SHEET 4 B 5 ARG A 222 MET A 227 -1 O MET A 227 N ALA A 177 SHEET 5 B 5 LEU A 213 THR A 219 -1 N LYS A 214 O VAL A 226 SHEET 1 C 2 LEU A 280 LEU A 282 0 SHEET 2 C 2 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 SSBOND 1 CYS A 60 CYS A 77 1555 1555 2.03 SSBOND 2 CYS A 296 CYS A 310 1555 1555 2.05 CISPEP 1 ARG A 67 PRO A 68 0 2.71 SITE 1 AC1 21 ASN A 53 ASN A 54 GLN A 59 LEU A 78 SITE 2 AC1 21 GLN A 79 TRP A 80 ILE A 84 LEU A 210 SITE 3 AC1 21 THR A 211 VAL A 270 VAL A 271 TYR A 272 SITE 4 AC1 21 ARG A 273 ASP A 274 ILE A 290 ASP A 292 SITE 5 AC1 21 TYR A 326 HOH A 603 HOH A 635 HOH A 706 SITE 6 AC1 21 HOH A 752 SITE 1 AC2 2 LYS A 163 EDO A 503 SITE 1 AC3 3 MET A 147 ARG A 222 SBT A 502 CRYST1 44.508 88.214 126.936 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022468 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011336 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007878 0.00000